Log in

603707 Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. SSE · China

Nanjing King-friend Biochemical Pharmaceutical Co. (603707) news

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 603707, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Nanjing King-friend Biochemical Pharmaceutical Co. news

We have not published a story on Nanjing King-friend Biochemical Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Nanjing King-friend Biochemical Pharmaceutical Co.

What is the ticker symbol of Nanjing King-friend Biochemical Pharmaceutical Co.?

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. trades under the ticker 603707 on SSE.

Where is Nanjing King-friend Biochemical Pharmaceutical Co. listed?

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is listed on SSE.

Which country or territory is Nanjing King-friend Biochemical Pharmaceutical Co. listed under?

Our directory records Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. under China.

What does Nanjing King-friend Biochemical Pharmaceutical Co. do?

Our directory classifies Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Nanjing King-friend Biochemical Pharmaceutical Co.?

The ISIN recorded for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is CNE100002WP3.

Does aibio.space cover Nanjing King-friend Biochemical Pharmaceutical Co.?

aibio.space lists Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Nanjing King-friend Biochemical Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Nanjing King-friend Biochemical Pharmaceutical Co.: Youcare Pharmaceutical Group Co., Shanghai Jiaoda Onlly Co., BeBetter Med, Beijing Aosaikang Pharmaceutical Co., Guiyang Xintian Pharmaceutical Co., Tiansheng Pharmaceutical Group Co..

Investor discussion: Nanjing King-friend Biochemical Pharmaceutical Co.

Members talk about Nanjing King-friend Biochemical Pharmaceutical Co. (603707). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:603707 on TradingView.

Listing details

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 603707, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Ticker
603707
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100002WP3
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.